Sign up for periodic reports and bulletins
FREE access; FREE of commercials; FREE to use
Posted April 15, 2016: by Bill Sardi
“What’s up doc?” – Bugs Bunny with a carrot in his mouth
Move over Bugs Bunny. Your beta carotene-rich carrots which converts to vitamin A in the liver to eventually form rhodopsin, the visual chemical of sight at the back of the eyes, is about to get bumped to second place by a cup of java.
So far, cataract surgeons, as effective as they are at restoring sight these days with lens implants (even multi-focal intraocular lenses) with 95+% success, have been able to deny eye drops for cataracts are effective at delaying or totally preventing cataracts.
Posted April 11, 2016: by Bill Sardi
Despite its unconvincing history and its blunt but cursory dismissal by modern medicine, vitamin C therapy for cancer may (finally) be undergoing an unexpected resurgence and it isn’t being led by a bunch of naturopaths and vitamin wackos.
Scientific investigators from 13 different countries operating at 28 universities and established clinics have published 37 papers in the past four years on the need to produce more evidence of vitamin C’s safety and efficacy for cancer treatment. In other words, vitamin C therapy is not dead and buried 37 years after it was first introduced by Nobel Laureate Linus Pauling and Scottish physician Ewan Cameron.
Posted April 8, 2016: by Bill Sardi
A modern reanalysis reveals there are ways to optimize vitamin C therapy and significantly prolong the lives of cancer patients.
In 1978 Dr. Ewan Cameron and Nobel Laureate Linus Pauling published a study that reported long-term survival of cancer patients who had undergone intravenous + oral mega-dose (10,000 milligrams) vitamin C therapy. Vitamin C-treated cancer patients lived 20 times longer than a control group. While most patients succumbed to their cancer, intravenous vitamin C therapy outperformed conventional cancer therapy. By comparison, 0.4% of cancer patients who did not undergo vitamin C therapy survived 1-year versus 22% who had undergone intravenous vitamin C therapy. [Proceedings National Academy Science 1978]
Posted March 7, 2016: by Bill Sardi
Labeled as “health fanatics” and “vitamin whackos,” the users of mega-dose vitamin C pills are about to be vindicated. No more hiding their vitamin C pills from their doctors. No more condescending glances from their friends when they say they are taking a few grams of vitamin C every day. According to newly revealed science, the belittled mega-dose vitamin C users may be purchasing the cheapest and most effective health insurance one can buy.
The prevalent belief is that vitamin C is an essential nutrient but excessive amounts consumed from mega-dose vitamin pills produce expensive urine since excesses are excreted. This flawed idea emanates from studies conducted by researchers at the National Institutes of Health (NIH) in 1996. [Proceedings Natl. Academy Science 93:14344-8, 1996] Ever since then physicians, pharmacists, dietitians and other health practitioners have echoed the same mistaken chorus — you’re wasting your money by taking mega-dose vitamin C pills.
Posted February 5, 2016: by Bill Sardi
The U.S. Food & Drug Administration (FDA) is loath to monitor the safety of drugs following their initial approval. More than a decade after shortcomings within the U.S. Food & Drug Administration in conducting follow-up safety studies after new drugs are approved were identified, the General Accounting Office (GAO) says the FDA is still dragging its feet by utilizing technology that requires manual entry of data.
In January of 2016 the General Accounting Office (GAO) of the U.S. finally got around to find out why it has taken the Food & Drug Administration so long to require drug companies to publish all of their follow-up safety data once their drugs gain regulatory approval.
In an era when the FDA is conceding to pressure to approve new drugs more rapidly, it is not properly monitoring safety of these drugs as it should, says the GAO report. The GAO found that more than half of drug sponsors’ submissions involving about 1400 post-market studies required or requested from the FDA between March 2008 and September 2013 were delayed or overdue.
Posted January 16, 2016: by Bill Sardi
I have written extensively at LewRockwell.com about cholesterol and statin drugs: A new injectable cholesterol drug (July 28, 2015); When will modern medicine give up its cholesterol cash-cow? (Dec 27, 2013); Statin cholesterol-lowering drugs work via reduction of iron (May 27, 2013); Statin drugs don’t save lives (Nov 10, 2008); Coronary calcium predicts future heart attacks, not cholesterol (March 28, 2008); Who will tell the people? It isn’t cholesterol. (Feb 5, 2007);
There have been numerous other critics of statin drugs: Don’t give more patients statins, John Abramson/Rita Redberg, NY times (Nov 13, 2013); The Great Cholesterol Con, Malcolm Kendrick (Oct 1, 2008); The Cholesterol Myths, Uffe Ravnskov (Oct 1, 2000); The Statin Damage Crisis, Duane Graveline (July 29, 2012); Lipitor Thief Of Memory, Duane Graveline (Sept 23, 2010)
Yet the American population has been systematically educated and can be considered a nation of ingrained cholesterol phobes and the statin drug industry continues to rake in billions of dollars in revenues.
Posted January 11, 2016: by Bill Sardi
Time is running out, better get your flu shot. That’s what news agencies around the country are urging Americans to do. Roll up their sleeves, despite the fact it’s too late to really develop adequate antibody defense, and get jabbed with a largely ineffective and somewhat problematic flu vaccine.
While the Centers for Disease Control says the flu strikes 5-to-20% of the population in any given year, the flu is only evident in 0.8 to 1.3% of the blood samples taken from virally-infected individuals so far this year. [Centers Disease Control]
Public health authorities appear dumbfounded. “It is a very slow season, locally, statewide, and nationally,” said Caroline Johnson, director of disease control for the Philadelphia Department of Public Health. “Everything seems to be much lower than usual.” [Philly.com]
Posted December 14, 2015: by Bill Sardi
Amidst a modern world where pharmacologists want the world to believe only high-priced synthetic molecules are safe and effective, and the Food & Drug Administration adds to this racketeering by limiting disease prevention/treatment/cure claims to drugs only, there is a growing body of science which shows clove bud oil and its primary active ingredient eugenol (yu-jen-all) could replace many over-the-counter and prescription medicines as a safer and equally or more effective topical anesthetic, pain reliever and fever reducer with anti-inflammatory, anti-depressant, anti-bacterial and anti-fungal properties and also holds the title as king of antioxidants. So why aren’t we using it?
Posted November 29, 2015: by Bill Sardi
According to the US Department of Agriculture (USDA) nutritional deficiencies are rampant in over-fed/undernourished America. Just a sampling from the USDA list of essential nutrients that are not consumed in sufficient amounts by a percentage of the population includes vitamin E (86.4%), folic acid (40.3%), magnesium (57%), potassium (92.4%), vitamin C (42%), zinc (29.2%). [Knowledge of Health]
The Recommended Daily Allowance for essential nutrients is generally too low and the above figures don’t even approach the massive nutrient shortages in the population at large.
Posted November 14, 2015: by Bill Sardi
A team of university-based medical ethicists has given Big Pharma an “F” grade on reporting requirements for new drugs. [Medical Express]
Their research report said: “It may seem difficult to understand failures to comply with federal law, now eight years old, whose origins track back to 1997, and even more difficult to understand failures to meet the over-riding ethics obligation that human research be designed to contribute to generalizable knowledge.”